Using Monoclonal Antibody Therapies for Multiple Sclerosis: A Review

被引：7
|
作者：
Elsbernd, Paul M. [1 ]
Carter, Jonathan L. [1 ]
机构：
[1] Mayo Clin, Dept Neurol, 13400 East Shea Blvd, Scottsdale, AZ 85259 USA
来源：
BIOLOGICS-TARGETS & THERAPY | 2021年 / 15卷
关键词：
monoclonal antibodies; multiple sclerosis; relapsing; progressive; review; NATALIZUMAB ANTIBODIES; INTERFERON BETA-1A; CONTROLLED TRIAL; RISK; ALEMTUZUMAB; RITUXIMAB; OCRELIZUMAB; PLACEBO; MECHANISMS; SAFETY;
D O I：
10.2147/BTT.S267273
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
Monoclonal antibody therapies have secured an important role in the therapeutic landscape for the treatment of both relapsing and progressive forms of multiple sclerosis due to their potent efficacy, convenient dosing schedules, and well-defined side effect profiles. Each therapy has unique risks and benefits associated with its specific mechanism of action which ultimately guides clinical decision-making for individual patients. This review will summarize the mechanisms of action, evidence leading to their approval, and clinically relevant considerations for each of the current monoclonal antibody therapies approved for the treatment of multiple sclerosis.
引用
收藏
页码：255 / 263
页数：9
相关论文
共 50 条
  • [1] Emerging monoclonal antibody therapies for multiple sclerosis
    Cree, Bruce
    NEUROLOGIST, 2006, 12 (04) : 171 - 178
  • [2] Recent Advances in Monoclonal Antibody Therapies for Multiple Sclerosis
    Wootla, Bharath
    Watzlawik, Jens O.
    Stavropoulos, Nikolaos
    Wittenberg, Nathan J.
    Dasari, Harika
    Abdelrahim, Murtada A.
    Henley, John R.
    Oh, Sang-Hyun
    Warrington, Arthur E.
    Rodriguez, Moses
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2016, 16 (06) : 827 - 839
  • [3] Monoclonal Antibody Therapies for Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder
    Kim, Woojun
    Kim, Ho Jin
    JOURNAL OF CLINICAL NEUROLOGY, 2020, 16 (03): : 355 - 368
  • [4] A review of monoclonal antibody therapies in lymphoma
    Teo, Esmeralda Chi-yuan
    Chew, Yveline
    Phipps, Colin
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2016, 97 : 72 - 84
  • [5] Monoclonal antibody treatments for multiple sclerosis
    Rose, John W.
    Foley, John F.
    Carlson, Noel G.
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2009, 11 (03) : 211 - 220
  • [6] Monoclonal antibody treatments for multiple sclerosis
    John W. Rose
    John F. Foley
    Noel G. Carlson
    Current Treatment Options in Neurology, 2009, 11 : 211 - 220
  • [7] Monoclonal antibody treatments for multiple sclerosis
    Rose, John W.
    Foley, John
    Carlson, Noel
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2008, 8 (05) : 419 - 426
  • [8] Monoclonal antibody treatments for multiple sclerosis
    John W. Rose
    John Foley
    Noel Carlson
    Current Neurology and Neuroscience Reports, 2008, 8 : 419 - 426
  • [9] Monoclonal antibody treatment of multiple sclerosis
    Coles, A.
    IMMUNOLOGY, 2010, 131 : 24 - 24
  • [10] UTILISATION OF MONOCLONAL ANTIBODY THERAPIES AMONG PATIENTS WITH MULTIPLE SCLEROSIS IN 5EU AND THE US
    Patel, R. P.
    Gabriele, S.
    Brown, H.
    Teoh, S.
    Clark, L. A.
    Karki, C.
    VALUE IN HEALTH, 2019, 22 : S378 - S378
12345